By www.reliablemarketsize.com
Global Chimeric Antigen Receptor T Cell Therapy Market Research Report 2024 Story
95
$ 2900
Chimeric Antigen Receptor T Cell Therapy Report report is categorised based on following features:
1. Global Market Players
2. Geopolitical regions
3. Consumer Insights
4. Technological advancement
5. Historic and Future Analysis of the Market
Amgen Bellicum Pharmaceuticals Bluebird Bio Caribou Biosciences Celgene Corporation Cellectis Celyad Oncology Gilead Sciences Intellia Therapeutics Johnson & Johnson Legend Biotech Merck Noile-Immune Biotech Novartis Pfizer Sangamo Therapeutics Servier Laboratories